STAHL NEIL 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Feb 8, 2024
Insider Transaction Report
Form 4
STAHL NEIL
SVP Res and Dev Sciences
Transactions
- Sale
Common Stock
2024-02-07$947.34/sh−100$94,734→ 59,956 total - Sale
Common Stock
2024-02-07$949.45/sh−601$570,619→ 57,461 total - Sale
Common Stock
2024-02-07$951.49/sh−1,237$1,176,993→ 53,097 total - Sale
Common Stock
2024-02-07$953.00/sh−19$18,107→ 52,019 total - Sale
Common Stock
2024-02-07$948.69/sh−1,894$1,796,819→ 58,062 total - Sale
Common Stock
2024-02-07$950.43/sh−3,127$2,971,995→ 54,334 total - Sale
Common Stock
2024-02-07$952.49/sh−1,059$1,008,687→ 52,038 total
Holdings
- 5,834(indirect: By 401(k))
Common Stock
- 4,605(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Represents volume-weighted average price of sales of 1,894 shares of Company stock on February 7, 2024 at prices ranging from $948.19 to $948.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
- [F2]Represents volume-weighted average price of sales of 601 shares of Company stock on February 7, 2024 at prices ranging from $949.22 to $949.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 3,127 shares of Company stock on February 7, 2024 at prices ranging from $950.00 to $950.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 1,237 shares of Company stock on February 7, 2024 at prices ranging from $951.00 to $951.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 1,059 shares of Company stock on February 7, 2024 at prices ranging from $952.03 to $952.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 7, 2024 at each separate price.